CHICAGO (September 11, 2008) — McDermott Will & Emery is hosting five upcoming life science-related events for clients and guests around the United States. Lawyers from the Firm’s Life Sciences & Medical Device Practice Group will be participating in each of these events.
IP Roundtable - Freedom to Operate: The New Rules
September 16, 2008 - San Diego Marriott Del Mar
September 17, 2008
McDermott Will & Emery - Silicon Valley office
Held in both San Diego and Silicon Valley, this roundtable will focus on successfully developing a freedom-to-operate business model by integrating an effective regulatory compliance infrastructure into your life sciences or medical device business. Panelists will identify new trends and discuss the new rules in today's environment that govern the sustainability of the freedom to operate as a product moves through its development and commercialization cycles. The panelists for the roundtable are McDermott partners Bill Gaede; Michele Moreland; T. Reed Stephens; and Peter Townshend.
IP Roundtable - Licensing and Litigation Strategies in the Wake of MedImmune, SanDisk and Quanta
October 1, 2008 - Hyatt Regency Princeton (New Jersey)
This roundtable focuses on how recent court decisions will affect ongoing IP licensing and enforcement programs. The interactive session will explore emerging trends in patent law, including what the recent Supreme Court and Federal Circuit decisions mean for managing intellectual property assets and coordinating patent strategy with business objectives.
Health Care Fraud and Abuse Law for Pharmaceutical, Biotech and Medical Device Counsel
October 15, 2008 - McDermott Will & Emery - Chicago office
This event will address the recent revisions to PhRMA Code of Interactions with Healthcare Professionals and AdvaMed Code of Ethics on Interaction with Healthcare Professionals. Additionally, panelists will discuss recent FDA-related matters including off-label promotions, manufacturing practices and clinical trials; and government price reporting obligations and potential fraud and abuse liability and its enforcement landscape. Irene P. Jakimcius, Chief Regulatory Counsel at Baxter International, Inc. will serve as a panelist as well as McDermott partners Joan Polacheck and T. Reed Stephens.
Life Sciences Roundtable - Strategies for Today’s Life Sciences Industry:
What’s Keeping You Awake at Night?
October 16, 2008 - The Westin - Waltham, Boston
Industry insiders will discuss the sustainability for life sciences companies in the turbulent economy—innovative strategies, viable financing and licensing opportunities outside the United States, and techniques to accelerate the clinical trial and regulatory processes. A panel will also address the need for competing industry leaders to collaborate at the research, research funding and commercialization levels. Topics include how to manage the decline in National Institutes of Health funding and eliminating cultural and intellectual property barriers to better foster collaboration. The panel includes McDermott partners Stephen W. Bernstein, Sarah Columbia and Robert Underwood.
McDermott’s Life Sciences & Medical Devices Practice Group provides fully integrated, multidisciplinary legal services to the life sciences industry. The practice group of 135+ lawyers, patent agents and scientific advisors provides the full range of legal services required by life sciences companies, regardless of their stage of development. Our lawyers understand the specific needs of companies in this industry and can significantly support in-house counsel through various stages of their products and services life cycle.